PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Open-sourcing the future of food

Tufts University's new cell bank makes cultivated-meat tech public

2026-01-13
(Press-News.org) For the last two years, the cultivated meat industry has been experiencing growing pains. Many startups have shrunk, shut down, or pivoted. Their advances aren’t going to waste, though.

The Tufts University Center for Cellular Agriculture (TUCCA), which seeks to enable production of meat, milk, and eggs from cells instead of animals, has teamed up with nonprofit partner Good Food Institute to salvage the intellectual property—the inventions—of those firms and make them publicly available to help nurture the industry. 

Specifically, this effort aims to obtain and broadly distribute cell lines—cells of a specific type that can be grown indefinitely in a solution containing nutrients, or media. The cell lines can then be used to generate cultivated meat, an alternative product which can enhance the efficiency, resiliency, and product diversity of our food system. 

By obtaining these cell lines and making them widely available, Tufts and the Good Food Institute can rescue years of effort and millions of dollars of company R&D which would otherwise be lost after company closures.

For example, in 2023 San Francisco startup SCiFi Foods began growing beef cell lines for food. They raised a total of $40 million over several funding rounds, and had developed a hybrid burger of 90% soy protein and 10% cultivated beef cells, submitting their cultivated beef to the FDA for regulatory approval.

That same year, though, investors started to cool on cultivated meat. The poor funding environment led to SCiFi Foods’ closure, and its assets were sold at auction—including their cell lines. 

“We didn’t know who else might show up for the auction, but collectively agreed it would be a shame for SCiFI’s technology to get locked in a box somewhere, so we were excited that GFI decided to bid,” said Meera Zassenhaus, director of communications for TUCCA. 

The Good Food Institute had the winning bid, buying eight cell lines and the recipes for two serum-free (meaning no animal product) media formulations competitively at auction, which it then transferred to Tufts for storage and validation with the intent of making them available for others to use and further develop.

These cell lines include the three most commercially developed beef cell lines from the company, which have all been modified by the gene-editing technology CRISPR to ensure their ability to grow indefinitely in culture, and subsequently adapted to grow in scalable single-cell suspensions, like a “soup” of cells. Two of these cell lines have been further engineered to remove antibiotic resistance markers (genes inserted in the R&D process), thus making them suitable for food applications. 

The plan is for the cells to be part of an open access cell bank maintained by the Tufts Cellular Agriculture Commercialization Lab, which is currently raising funds to build out its infrastructure and develop additional cells from various livestock and harvested animal species.

“We’ll make them available with very few restrictions on use,” said Andrew Stout, an assistant professor in the Tufts biomedical engineering department who is leading cell bank efforts.

The cell bank will be housed in TUCCA’s upcoming future foods innovation hub, to offer shared-use prototyping and scale-up research facilities, incubator lab space for startups to co-locate, and a network of experts to accelerate cellular agriculture development in Massachusetts and globally.

What Makes SCiFi’s Beef Cell Line Special  Stout and the Good Food Institute’s senior principal scientist for cultivated meat Elliot Swartz led the effort to evaluate SCiFi’s portfolio for the best candidates to initially offer through the cell bank. “The most exciting feature about the first cell lines is that they can be grown in single-cell suspension,” said Stout. 

Single-cell suspension means they grow with the cells floating freely in solution, forming a slurry of sorts, in contrast to most cells that require something to attach to and then be scraped off of, like the surface of a culture dish. “That allows for simple, large-scale production in bioreactors, making them the first such livestock-based cell lines broadly available to the field,” he said. 

“There’s a lot of research that can be done about figuring out how to make other cell lines grow in single-cell suspension,” said Natalie Rubio, EG22, executive director of the Cellular Agriculture Commercialization Lab, which is leading the banking and distribution of the cells as part of its larger mission to commercialize promising technologies. “The cells we acquired will open the door for some more scalable research, like bioreactor optimization.”

In addition to the eight bovine cell lines from SCiFi, the TUCCA cell bank plans to offer additional cells developed at Tufts, including bovine, mackerel, and pork lines. According to Zassenhaus, TUCCA and Good Food Institute expect high demand for the cells, with an official waitlist form to register interest available. 

“We are essentially composting intellectual property, or IP, from an individual start-up and transforming it into a public good to benefit the entire field,” said Zassenhaus. “This model of IP re-use makes sense for all kinds of technologies even beyond alternative proteins, especially as climate tech broadly faces a contraction in funding.”

END


ELSE PRESS RELEASES FROM THIS DATE:

Changes in genetic structure of yeast lead to disease-causing genomic instabilities

2026-01-13
Osaka, Japan – Changes in genes have been linked to the development of different diseases for a while. However, it’s not exactly clear what the mechanisms, or the causes behind those specific genetic changes, are. Recent studies using fission yeast, which can act as an ideal model for human cells, have highlighted one possible mechanism linked to disease onset. In a study recently published in Nucleic Acids Research, researchers from The University of Osaka discovered that the loss of heterochromatin ...

UC San Diego Health Sciences Grant Writing Course helps launch successful research careers

2026-01-12
To launch a successful research career in the health sciences, junior faculty need to write persuasive, high-quality grant proposals that get funded. However, the skill is not widely taught in medical schools or graduate programs. In a new study, University of California San Diego researchers report that early career faculty who completed the institution’s innovative Health Sciences Grant Writing Course demonstrated significant increases in grant submission rates and funding success — especially among women and faculty ...

Study: Many head and neck cancer trials end early. Why?

2026-01-12
MIAMI, FLORIDA (Jan. 12, 2026) – Head and neck cancer trials are frequently derailed before they can deliver answers. A new analysis suggests that the most common reasons are sponsor decisions related to safety or effectiveness and poor patient recruitment. Researchers from Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, and collaborators analyzed 692 clinical trials launched between 2000 and 2024. Alex Reznik, M.D./Ph.D. student at the University of Miami and co-author, described the study as “A retrospective query of head and neck cancer clinical trials in which we compared ...

Tufts vice provost for research named Foreign Fellow of Indian National Science Academy

2026-01-12
Bernard Arulanandam, vice provost for research at Tufts University and professor of immunology at Tufts University School of Medicine, has been named a foreign fellow of the Indian National Science Academy. This honor recognizes his significant contributions to scientific research and his longstanding engagement with international scientific communities. The Indian National Science Academy, established in 1935, is India’s premier scientific body dedicated to advancing scientific inquiry ...

New model improves prediction of prostate cancer death risk

2026-01-12
Embargoed for release until 5:00 p.m. ET on Monday 12 January 2026    Follow @Annalsofim on X, Facebook, Instagram, Bluesky, and Linkedin              Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing ...

Two wrongs make a right: how two damaging variants can restore health

2026-01-12
Seattle, WA — In a groundbreaking study published in the in Proceedings of the National Academy of Sciences (PNAS), scientists at Pacific Northwest Research Institute (PNRI) have overturned a long-held belief in genetics: that inheriting two harmful variants in the same gene always worsens disease. Instead, the team found that, in many cases, two harmful variants can actually restore normal protein function. The research focused on a human enzyme called argininosuccinate lyase (ASL), ...

Overlooked decline in grazing livestock brings risks and opportunities

2026-01-12
For decades, researchers have focused on the problem of overgrazing, in which expanding herds of cattle and other livestock degrade grasslands, steppes and desert plains. But a new global study reveals that in large regions of the world, livestock numbers are substantially declining, not growing — a process the authors call destocking. “We often assume that rangelands are being degraded because we overgraze them, but the data show that it's not the whole story: nearly half of livestock production occurs in areas that have experienced destocking over the past 25 years,” said study co-author Osvaldo Sala, an ecologist and professor ...

Using rare sugars to address alcoholism

2026-01-12
Kyoto, Japan -- While investigating the FGF21-oxytocin-dopamine system, a mechanism that regulates sugar appetite, a team of researchers at Kyoto University noticed reports suggesting that the protein FGF21 may regulate alcohol ingestion. The team's original aim had been to address sugar appetite in lifestyle-related diseases, but since alcohol is a fermented product of sugar, they speculated that perhaps the body contains a system that recognizes both alcohol and sugar as the same entity. Excessive alcohol consumption is a major global health issue, and ...

Research alert: New vulnerability identified in aggressive breast cancer

2026-01-12
Researchers at University of California San Diego have identified a previously unrecognized treatment target for triple‑negative breast cancer (TNBC), the most aggressive subtype of breast cancer. Their new study reveals that a protein called PUF60 plays an essential role in helping TNBC cells grow and survive by controlling how key genes are spliced. In models of TNBC, disrupting the activity of PUF60 caused widespread errors in gene processing, resulting in DNA damage, cell‑cycle arrest and ultimately tumor cell death. ...

Ruth Harris honored with SSA Distinguished Service Award

2026-01-12
For her decades of thoughtful Society leadership and energetic committee participation, the Seismological Society of America  will present Ruth Harris with its 2026 Distinguished Service Award. Harris will receive the award at the 2026 SSA Annual Meeting. Harris, a senior research geophysicist at the U.S. Geological Survey, joined SSA in 1987. She was first elected as an SSA Board Member from 1997 to 2003. She served as SSA Vice President from 2005-2007, and twice as SSA President, from 2015-2016 and from 2023-2024. In ...

LAST 30 PRESS RELEASES:

The Lancet: COVID-19 vaccine hesitancy decreased over time, though mistrust persists among certain groups, study of over 1 million people in England suggests

Psychosis patients ‘living in metaphor’ -- new study radically shifts ideas about delusions

Clinical trial in Ethiopia targets the trachoma scourge

Open-sourcing the future of food

Changes in genetic structure of yeast lead to disease-causing genomic instabilities

UC San Diego Health Sciences Grant Writing Course helps launch successful research careers

Study: Many head and neck cancer trials end early. Why?

Tufts vice provost for research named Foreign Fellow of Indian National Science Academy

New model improves prediction of prostate cancer death risk

Two wrongs make a right: how two damaging variants can restore health

Overlooked decline in grazing livestock brings risks and opportunities

Using rare sugars to address alcoholism

Research alert: New vulnerability identified in aggressive breast cancer

Ruth Harris honored with SSA Distinguished Service Award

Treasure trove of data on aging publicly accessible

Trees4Adapt project to address risks from climate change and biodiversity loss through tree-based solutions

Nature Communications study from the Lundquist Institute identifies molecular mechanism underlying peripartum cardiomyopathy

Pennington Biomedical’s Dr. Gang Hu appointed to NIH Reproductive, Perinatal and Pediatric Health Review Group

World-first project shows great promise to treat low eye pressure

New technique puts rendered fabric in the best light

Brain cancer digital twin predicts treatment outcomes

Cat disease challenges what scientists thought about coronaviruses

Paulson Family Foundation makes an additional $19 million donation to Hebrew University to fund a new building for electrical engineering. Together with its previous gift brings the total donation to

Canada–Estonia partnership advances community-centered clean energy

Sandia’s economic impact sets record for 17th consecutive year

Researchers uncover how tumors become resistant to promising p53-targeted therapy

Aligning games and sets in determining tennis matches

UOC research team develops method to evaluate apps for treating depression

Extreme heat waves disrupt honey bee thermoregulation and threaten colony survival

New brain study explains how binge drinking contributes to long-lasting negative feelings

[Press-News.org] Open-sourcing the future of food
Tufts University's new cell bank makes cultivated-meat tech public